Medical Journals

Lutropin/Choriogonadotropin Stimulate the Proliferation of Primary Cultures of Rat Leydig Cells Through a Pathway That Involves Activation of the Extracellularly Regulated Kinase 1/2 Cascade.

Authors:
  • Shiraishi Koji
  • Ascoli Mario

From: Department of Pharmacology, Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242, USA.

Endocrinology

  • Publish Date: Jul 2007
  • ISSN: 0013-7227
  • Volume: 148
  • Issue: 7
  • Pages: 3214-25
  • Medium: Print
  • Language: English
  • Citation (JAMA): Shiraishi Koji, Ascoli Mario, et al. Lutropin/Choriogonadotropin Stimulate the Proliferation of Primary Cultures of Rat Leydig Cells Through a Pathway That Involves Activation of the Extracellularly Regulated Kinase 1/2 Cascade.. Endocrinology Jul 2007;148:3214-25

Abstract

Primary cultures of progenitor and immature rat Leydig cells were established from the testes of 21- and 35-d-old rats, respectively. The cell population remained homogeneous after 4-6 d in culture as judged by staining for 3beta-hydroxysteroid dehydrogenase, but the cells were unable to bind 125I-human chorionic gonadotropin (hCG) or to respond to hCG with classical LH receptor (LHR)-mediated responses, including cAMP and inositol phosphate accumulation, steroid biosynthesis, or the phosphorylation of ERK1/2. Infection of primary cultures with recombinant adenovirus coding for beta-galactosidase showed that approximately 65% of the cells are infected. Infection with adenovirus coding for the human LHR (hLHR) allowed for expression of the hLHR at a density of approximately 25,000 receptors per cell and allowed the cells to respond to hCG with increases in cAMP and inositol phosphate accumulation, steroid biosynthesis, and the phosphorylation of ERK1/2. Although progenitor and immature cells were able to respond to hCG with an increase in progesterone, only the immature cells responded with an increase in testosterone. In addition to these classical LHR-mediated responses, the primary cultures of progenitor or immature rat Leydig cells expressing the recombinant hLHR proliferated robustly when incubated with hCG, and this proliferative response was sensitive to an inhibitor of ERK1/2 phosphorylation. These studies establish a novel experimental paradigm that can be used to study the proliferative response of Leydig cells to LH/CG. We conclude that activation of the LHR-provoked Leydig cell proliferation requires activation of the ERK1/2 cascade.

Mesh Headings (Keywords): Animals, Blotting, Western, Butadienes, Cell Proliferation, Cells, Cultured, Chorionic Gonadotropin, Cyclic AMP, Dipeptides, Epidermal Growth Factor, Flavonoids, Immunohistochemistry, Inositol Phosphates, Leydig Cells, Luteinizing Hormone, Male, Mitogen-Activated Protein Kinase 3, Nitriles, Phosphorylation, Pyrazoles, Pyrimidines, Rats, Recombinant Proteins, Signal Transduction, Steroids, Tyrphostins


Check for Full Text / PubMed Unique Identifier (PMID): 17412805


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.